BeBevCo Signs Letter of Intent with CBD Cannabidiol Drinking Water Brand

Company finalizing plans to bring exciting product to market in 2016!

STATESVILLE, NC- (December 22, 2015) – Bebida Beverage Company (OTC: BBDA) BeBevCo, a developer, manufacturer, marketer of relaxation, energy drinks, and liquid dietary supplements has signed a “Letter of Intent” with a company who has developed a CBD flavored drinking water infused with cannabidiol and a high PH. The next steps is to develop a path to market. BeBevCo, becoming an exclusive sales and marketing partner for the USA markets. Both companies are already reviewing contracts and are hopeful for a Spring 2016 introduction to both, retail and distribution partners alike.

“What a great way to close out 2015. We are getting closer to see a clear picture for 2016 and beyond for BeBevCo.” Said BeBevCo’s CEO, Brian Weber. “We have multiple updates coming over the next week including a Shareholder update this week. This will help our shareholders understand better what obstacles we have overcome in 2015 and how they will make us stronger moving forward.” Brian added.

Find us on Facebook ( or follow on Twitter @KOMAUnwindNews.

Shareholders, investors and potential new distributors are invited to be added to the corporate e-mail database for the future distribution of corporate press releases and industry updates by sending an e-mail to

About BeBevCo:

BeBevCo (Bebida Beverage Company) develops manufactures and markets liquid relaxation products including, KOMA Unwind® Liquid Relaxation®, KOMA Unwind® Sugar-free Liquid Relaxation®, and KOMA Unwind Liquid Relaxation Shots®, as well as POTENCIA Energy, POTENCIA BLAST Energy Shots and Relax 5 Shots.

KOMA Unwind® currently garnishes over 75 percent of brand awareness in the rapidly expanding relaxation drink category in the United States. Additionally, KOMA Unwind® has been featured in The Oprah Magazine, Bloomberg News, the Wall Street Journal, Women’s Health and many other publications.

Corporate websites accessible at and

Investor Relations